News Chart OKYO Pharma Limited

Equities

Market Closed - Nasdaq Other stock markets 21:30:01 14/06/2024 BST			5-day change	1st Jan Change
1.308 ^USD	-3.82%		+3.00%	-26.10%

03-22	H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating	MT
03-22	OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101	CI

1b67355c5f6.qmvj5fwpdfIb_CfXgrwn-QjdOnW2bkraVamsSSHx2xE.-D-UsYoQDIZQhWyb3dlXzluIbUPsOTuCIuD5CHbH9nXTDpncqUwyvWnORA~0bb6ae945a9743913046b932d8758db6